

Oncotarget
Oncotarget Podcast
Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Oncotarget is now indexed by MEDLINE, PubMed and PMC/PubMed.
Read about the Oncotarget Scientific Integrity Process: https://www.oncotarget.com/scientific_integrity/
Oncotarget is now indexed by MEDLINE, PubMed and PMC/PubMed.
Read about the Oncotarget Scientific Integrity Process: https://www.oncotarget.com/scientific_integrity/
Episodes
Mentioned books

Apr 7, 2023 • 3min
Cancer-Associated Fibroblasts: Challenges and Opportunities
Researcher Hossein Tavana and expert Gary D. Luker discuss Cancer-associated fibroblasts' role in tumor microenvironment, challenges in targeting them for therapies, and the potential of personalized cancer treatments through better understanding of CAFs.

Apr 7, 2023 • 3min
Impact of Cortactin in Cancer Progression
Researchers Kamrul Hasan and Thomas J. Kipps from the University of California discuss the impact of cortactin in cancer progression, focusing on its role in promoting cell migration and metastasis. They explore its interactions with actin-related proteins, signaling pathways, and its association with cancers like CLL and breast cancer.

Apr 7, 2023 • 2min
Oncotarget at AACR Annual Meeting 2023
The podcast discusses the presence of Impact Journals at the AACR Annual Meeting 2023, emphasizing their focus on cancer and aging research. They invite visitors to connect with the team at Booth 2642 during the event.

Mar 31, 2023 • 7min
Targeting Pre-Leukemic Cells: New Hope for Preventing Childhood B-ALL
Researchers discuss targeting pre-leukemic cells to prevent childhood B-ALL, focusing on genetic mutations and environmental triggers. They explore the efficacy of Roxelitinib in reducing B-ALL incidence in mice and propose ongoing research for preventative strategies against childhood leukemia.

Mar 30, 2023 • 4min
Downregulation of Angulin-1/LSR Induces Malignancy in Lung Adenocarcinoma
Researchers discuss the impact of angulin-1/LSR downregulation on malignancy in lung adenocarcinoma. They explore abnormal claudin-2 expression and the effects of angulin-1/LSR loss on lung adenocarcinoma cell lines. The study also examines therapeutic approaches for lung adenocarcinoma via cell metabolism modulation, highlighting the potential of AG1478 and EW7197 as treatments.

Mar 28, 2023 • 5min
Polyisoprenylated Cysteinyl Amide Inhibitors Deplete G-Proteins in Cancer Cells
Researchers discuss the effectiveness of Polyisoprenylated Cysteinyl Amide Inhibitors in depleting G-proteins in lung and breast cancer cells. The study shows promising results with significant decreases in levels of key G proteins, offering potential as anti-cancer agents.

Mar 22, 2023 • 5min
Attenuation of Cancer Proliferation by Suppression of Glypican-1
Researchers Fang Cheng, Victor Chérouvrier Hansson, Grigorios Georgolopoulos, and Katrin discuss their recent study on Glypican-1 in cancer. They reveal the correlation between GPC-1 expression and poor prognosis in multiple cancer types. Targeting GPC-1 resulted in cancer cell growth inhibition, highlighting its potential in precision cancer treatment.

Mar 20, 2023 • 3min
Unlocking the Potential of Molecular-Driven Stratification of Osteosarcoma
Discover the complexity of genetic landscape and microenvironment in Osteosarcoma tumors through unsupervised machine learning algorithms. Explore stratification based on gene expression modules enriched for immune microenvironment and tumor phenotypic traits for improved treatment strategies.

Mar 17, 2023 • 6min
Unconventional Protein Secretion (UPS) in Cancer
Researchers discuss the unconventional protein secretion (UPS) in cancer, highlighting pathways like lysosome-mediated and exosome-mediated. They dive into the unique mechanisms observed in liver cancer cells, emphasizing the importance of differentiating between leaked and actively secreted proteins for targeted therapies.

Mar 14, 2023 • 4min
MTAP Loss in Metastatic Breast Cancer Patients: Genomic Landscape
Exploring the impact of MTAP loss on purine synthesis in metastatic breast cancer patients, analyzing genomic alterations and treatment strategies based on a recent study.